Clinical Trial Update: Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial updating combination chemotherapy with pazopanib in children and adolescents with relapsed or refractory solid tumors (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: Samsung Medical Center | Conditions: Relapsed Pediatric Solid Tumor, Refractory Pediatric Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN